newsfilter
← Latest News
GlobeNewswire·

Nasus Pharma CEO Issues 2025 Letter to Shareholders

TEL AVIV, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE:NSRX) ("Nasus Pharma", "Nasus" or the "Company"), a clinical-stage pharmaceutical company focused on the development of